Meningococcal Vaccines Market Size, Share, Growth Report 2030

Meningococcal Vaccines Market

Meningococcal Vaccines Market By Type (Combination Vaccines, Polysaccharide Vaccines, Conjugate Vaccines, and Men B Vaccines) and By End-User (Hospital Pharmacies, Retail Pharmacies, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-4775 Published Date: Sep-2019 Status : Published
Market Size in 2018 Market Forecast in 2025 Growth Rate (in %) Base Year
USD 3,833 Million USD 8,295 Million CAGR at 11.73%. 2018

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Meningococcal Vaccines Market, 2016-2025 (USD Million)
    • 2.2. Global Meningococcal Vaccines Market: Snapshot
  •  
  • Chapter 3. Meningococcal Vaccines Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Rising healthcare expenditure
      • 3.2.2. Changing lifestyles of females globally
    • 3.3. Market restraints
      • 3.3.1. Harmful reactions of drugs
      • 3.3.2. High cost
    • 3.4. Opportunities
      • 3.4.1. Technological advancement
      • 3.4.2. Increase in R&D activities
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Type
      • 3.6.2. Market attractiveness analysis, by End-User
      • 3.6.3. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Meningococcal Vaccines Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Meningococcal Vaccines Market: company market share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. R&D
      • 4.2.5. Regional Expansion
    • 4.3. Price Trend Analysis
    • 4.4. Type Portfolio
    • 4.5. Global Meningococcal Vaccines Market - Type Analysis
    • 4.6. Global Meningococcal Vaccines Market: Type overview
      • 4.6.1. Global meningococcal vaccines market share, by Type, 2018 and 2025
    • 4.7. Combination Vaccines
      • 4.7.1. Global Combination Vaccines Market, 2016-2025 (USD Million)
    • 4.8. Polysaccharide Vaccines
      • 4.8.1. Global Polysaccharide Vaccines Market, 2016-2025 (USD Million)
    • 4.9. Conjugate Vaccines
      • 4.9.1. Global Conjugate Vaccines Market, 2016-2025 (USD Million)
    • 4.10. Men B Vaccines
      • 4.10.1. Global Men B Vaccines Market, 2016-2025 (USD Million)
  •  
  • Chapter 5. Global Meningococcal Vaccines Market - End-User Analysis
    • 5.1. Global Meningococcal Vaccines Market: End-User overview
      • 5.1.1. Global Meningococcal Vaccines Market share, by End-User, 2018 and 2025
    • 5.2. Hospital Pharmacies
      • 5.2.1. Global Hospital Pharmacies Market, 2016-2025 (USD Million)
    • 5.3. Retail Pharmacies
      • 5.3.1. Global Retail Pharmacies Market, 2016-2025 (USD Million)
    • 5.4. Others
      • 5.4.1. Global Others Market, 2016-2025 (USD Million)
  •  
  • Chapter 6. Global Meningococcal Vaccines Market - Regional Analysis
    • 6.1. Global Meningococcal Vaccines Market: Regional overview
      • 6.1.1. Global Meningococcal vaccines market share, by region, 2018 and 2025
    • 6.2. North America
      • 6.2.1. North America Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
      • 6.2.2. North America Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
      • 6.2.3. The U.S.
        • 6.2.3.1. The U.S. Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
        • 6.2.3.2. The U.S. Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
      • 6.2.4. Rest of North America
        • 6.2.4.1. Rest of North America Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
        • 6.2.4.2. Rest of North America Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
    • 6.3. Europe
      • 6.3.1. Europe Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
      • 6.3.2. Europe Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
      • 6.3.3. Germany
        • 6.3.3.1. Germany Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
        • 6.3.3.2. Germany Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
      • 6.3.4. France
        • 6.3.4.1. France Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
        • 6.3.4.2. France Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
      • 6.3.5. UK
        • 6.3.5.1. UK Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
        • 6.3.5.2. UK Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
      • 6.3.6. Rest of Europe
        • 6.3.6.1. Rest of Europe Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
        • 6.3.6.2. Rest of Europe Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
      • 6.4.2. Asia Pacific Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
      • 6.4.3. China
        • 6.4.3.1. China Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
        • 6.4.3.2. China Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
      • 6.4.4. Japan
        • 6.4.4.1. Japan Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
        • 6.4.4.2. Japan Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
      • 6.4.5. India
        • 6.4.5.1. India Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
        • 6.4.5.2. India Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
      • 6.4.6. Rest of Asia Pacific
        • 6.4.6.1. Rest of Asia Pacific Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
        • 6.4.6.2. Rest of Asia Pacific Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
      • 6.5.2. Latin America Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
      • 6.5.3. Brazil
        • 6.5.3.1. Brazil Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
        • 6.5.3.2. Brazil Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
      • 6.5.4. Rest of Latin America
        • 6.5.4.1. Rest of Latin America Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
        • 6.5.4.2. Rest of Latin America Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
    • 6.6. The Middle East and Africa
      • 6.6.1. The Middle East and Africa Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
      • 6.6.2. The Middle East and Africa Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
  •  
  • Chapter 7. Company Profile
    • 7.1. Novartis International
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Type portfolio
      • 7.1.4. Business strategy
      • 7.1.5. Recent developments
    • 7.2. Nuron Biotech
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Type portfolio
      • 7.2.4. Business strategy
      • 7.2.5. Recent developments
    • 7.3. GlaxoSmithKline
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Type portfolio
      • 7.3.4. Business strategy
      • 7.3.5. Recent developments
    • 7.4. Pfizer
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Type portfolio
      • 7.4.4. Business strategy
      • 7.4.5. Recent developments
    • 7.5. Sanofi
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Type portfolio
      • 7.5.4. Business strategy
      • 7.5.5. Recent developments
    • 7.6. JN-International Medical
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Type portfolio
      • 7.6.4. Business strategy
      • 7.6.5. Recent developments
    • 7.7. Baxter International
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product Type portfolio
      • 7.7.4. Business strategy
      • 7.7.5. Recent developments
    • 7.8. Serum Institute of India
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product Type portfolio
      • 7.8.4. Business strategy
      • 7.8.5. Recent developments
    • 7.9. Biomed
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product Type portfolio
      • 7.9.4. Business strategy
      • 7.9.5. Recent developments

Table Of Figures

List of Figures 

1. Market Research Process
2. Market Research Methodology
3. Global meningococcal vaccines market revenue, 2016–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Meningococcal vaccines market attractiveness analysis, by Type
6. Meningococcal Vaccines Market attractiveness analysis, by End-User
7. Meningococcal Vaccines Market attractiveness analysis, by Region
8. Company market share analysis, 2018
9. Global Meningococcal vaccines market share by Type, 2018 and 2025
10. Global Combination Vaccines Market, 2016–2025 (USD Million)
11. Global Polysaccharide Vaccines Market, 2016–2025 (USD Million)
12. Global Conjugate Vaccines Market, 2016–2025 (USD Million)
13. Global Men B Vaccines Market, 2016–2025 (USD Million)
14. Global Meningococcal vaccines market share by End-User, 2018 and 2025
15. Global Hospital Pharmacies market, 2016–2025 (USD Million)
16. Global Retail Pharmacies market, 2016–2025 (USD Million)
17. Global others market, 2016–2025 (USD Million)


Table Of Tables

List of Tables

1. Meningococcal Vaccines Market: Snapshot
2. Drivers of the global Meningococcal Vaccines Market: Impact analysis 
3. Restraints of the global Meningococcal Vaccines Market: Impact analysis 
4. North America Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
5. North America Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
6. The U.S. Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
7. The U.S. Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
8. Rest of North America Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
9. Rest of North America Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
10. Europe Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
11. Europe Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million) 
12. U.K. Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
13. U.K. Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million) 
14. Germany Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
15. Germany Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million) 
16. France Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
17. France Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million) 
18. Rest of Europe Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
19. Rest of Europe Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million) 
20. Asia Pacific Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
21. Asia Pacific Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million) 
22. China Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
23. China Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million) 
24. Japan Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
25. Japan Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million) 
26. India Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
27. India Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million) 
28. Rest of Asia Pacific Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
29. Rest of Asia Pacific Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million) 
30. Latin America Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
31. Latin America Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million) 
32. Brazil Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
33. Brazil Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million) 
34. Rest of Latin America Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
35. Rest of Latin America Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million) 
36. The Middle East and Africa Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
37. The Middle East and Africa Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)

Methodology

Free Analysis

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed